PROZAC (fluoxetine hydrochloride) capsules – Prescribing Information, Section 12.1 Mechanism of Action (2026)

Government Record · Eli Lilly and Company / DailyMed (U.S. National Library of Medicine) · January 8, 2026

Eli Lilly, 2026-01-08: The FDA-approved fluoxetine label describes the drug's action as inhibition of neuronal serotonin uptake, and section 12.2 adds that fluoxetine blocks serotonin uptake into human platelets; no receptor blockade is claimed.

Although the exact mechanism of PROZAC is unknown, it is presumed to be linked to its inhibition of CNS neuronal uptake of serotonin.

Eli Lilly, 2026-01-08: The FDA-approved fluoxetine label describes the drug's action as inhibition of neuronal serotonin uptake, and section 12.2 adds that fluoxetine blocks serotonin uptake into human platelets; no receptor blockade is claimed. SPL effectiveTime 2026-01-08 (DailyMed record, access date 2026-11-21). SPL XML retrieved through the DailyMed API for this setid; the drugInfo page for the same setid returns HTTP 200. Section 12.1. pdf_url is DailyMed's direct PDF of the same label (getFile.cfm), opened and confirmed to return the label PDF. Study type: regulatory record.